FDA — authorised 6 December 1996
- Marketing authorisation holder: AMAG PHARMS INC
- Status: approved
FDA authorised Gastromark on 6 December 1996
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 6 December 1996.
AMAG PHARMS INC holds the US marketing authorisation.